Dementia Matters cover image

Our Evolving Understanding of Mild Cognitive Impairment

Dementia Matters

00:00

Alzheimer's Disease and Amyloid Removing Therapy - What Are Your Thoughts?

Lacanumab showed it did remove amyloid from the brain over the course of the 18-month study. Another one was presented at the meeting Ganton neuromab which removed some of the amyloid. So I think these monoclonal antibodies do what they're supposed to do. But the study on Lacanumab last week really talked about the fact that it may slow the progression of the disease.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app